ArticleFrontiers in immunology2022

Innate immune function during antineoplastic treatment is associated with 12-months survival in non-small cell lung cancer.

Heidi Ryssel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.